People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trxade Group, Inc. | — | Pharmaceuticals | Series C | $74.2M | $10.4M | 2024 |
| Scienture Inc. | — | Pharmaceuticals | Series A | $6.0M | $185.8M | 2019 |
Shankar Hariharan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shankar Hariharan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael L Peterson | 1 | 4 |
| Michael Peterson | 1 | 3 |
| Charles L. Pope | 1 | 2 |
| Prashant Patel | 1 | 2 |
| Howard A. Doss | 1 | 1 |
| Fernando Sanchez | 1 | 1 |
| Donald Fell | 1 | 1 |
| Howard Doss | 1 | 1 |
| Subbarao G. Jayanthi | 1 | 1 |
| Narasimhan Mani | 1 | 1 |
| Mayur G. Doshi | 1 | 1 |
| Mayur Doshi | 1 | 1 |
| Surendra Ajjarapu | 1 | 1 |
| Subbarao Jayanthi | 1 | 1 |
| Donald G. Fell | 1 | 1 |
| Suren Ajjarapu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.